Affymax Stock

Affymax P/B

The P/B (Price-to-Book Ratio) of Affymax (AFFY) as of Aug 15, 2026 is -0.02.

P/B

-0.02

Last updated:

P/B (Price-to-Book Ratio) of Affymax is 2026 -0.02 . P/B (Price-to-Book Ratio) of Affymax was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Affymax Stock analysis

What does Affymax do? Affymax Inc is a leading biotechnology company specializing in the development of innovative therapeutics for patients with serious diseases. The company was founded in 2001 and is headquartered in Palo Alto, California. Affymax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Affymax stock

P/B (Price-to-Book Ratio) of Affymax is -0.02 in 2026.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Affymax since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Affymax with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Affymax

All Key Metrics — Affymax